Passage Bio to Present at Guggenheim Securities Healthcare Innovation ConferenceGlobeNewsWire • 11/06/24
Passage Bio Presents Preclinical and Interim Clinical Data for PBFT02 in FTD-GRN at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual ConferenceGlobeNewsWire • 10/24/24
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment ConferenceGlobeNewsWire • 08/30/24
Passage Bio Reports Second Quarter 2024 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 08/08/24
Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research CollaborationGlobeNewsWire • 08/01/24
Passage Bio Announces Positive Feedback from FDA on Expansion of upliFT-D Trial of PBFT02 to Include FTD-C9orf72 PatientsGlobeNewsWire • 07/16/24
Passage Bio (PASG) Loses -22.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 06/18/24
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare ConferenceGlobeNewsWire • 06/05/24
Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship AwardGlobeNewsWire • 05/21/24
All You Need to Know About Passage Bio (PASG) Rating Upgrade to BuyZacks Investment Research • 05/16/24
Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 05/14/24
Passage Bio to Present at Chardan's 8th Annual Genetic Medicines and Cell Therapy Manufacturing SummitGlobeNewsWire • 04/22/24
Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should KnowZacks Investment Research • 03/07/24
Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 03/04/24
Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceGlobeNewsWire • 01/31/24
Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic PrioritiesGlobeNewsWire • 12/20/23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business HighlightsGlobeNewsWire • 11/13/23
Passage Bio to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology ConferenceGlobeNewsWire • 10/30/23